Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,764.40
(
-0.13%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.65
(
0.21%
)
Bitcoin
70,598.00
(
0.99%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 35943

Friday, 10/20/2006 6:27:35 PM

Friday, October 20, 2006 6:27:35 PM

Post# of 257262
Addendum re SGP and HCV acquisitions:

Although Hassan did not mention HCV acquisitions, specifically, during today’s CC, he evidently did in an interview later in the day.

http://yahoo.reuters.com/news/articlehybrid.aspx?storyID=urn:newsml:reuters.com:20061020:MTFH90654_2...

>>
"Our cash flow is going very nicely, which allows us to be more opportunistic, move faster and look at interesting deals," Hassan said in an interview. He said he was particularly keen on acquiring new products to treat cancer, hepatitis C and inflammation.
<<

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now